Will “Apifiny” be helpful in the diagnosis of prostate cancer?

The development-stage test known as Apifiny is a new type of test that its creators believe will help in the more accurate diagnosis of prostate cancer. Whether that is actually the case seems to be rather less certain as yet. … READ MORE …

James Mohler talks prostate cancer on CureTalk

On Tuesday this week, Dr. James L. Mohler of Roswell Park Cancer Institute participated in an hour-long discussion on key issues related to the diagnosis and management of early stage prostate cancer. … READ MORE …

The value of the PCA3 test: a multi-center study

The prostate cancer antigen 3 or PCA3 test was initially approved as an aid to the assessment of risk of prostate cancer in men with an elevated PSA level who had already been given at least one prior, negative biopsy. … READ MORE ..

cfDNA from blood samples as a way to measure prostate cancer risk

According to a new article in the journal Clinical Chemistry, an international research team believes they have found a completely new way to test for risk of prostate cancer by measuring tumor-specific, cell-free DNA (cfDNA) in blood samples (serum and plasma). … READ MORE …

Why we get cancer: genetics, lifestyle, and just sheer chance

It has long been understood that many cancers occur as a consequence of errors in the replication of the genetic materials of cells (usually DNA) during the normal process of cell growth and replication. … READ MORE …

NICE concludes that PCA3, phi tests not clinically useful

The National Institute for Health and Care Excellence (NICE) has issued draft guidance stating that two approved tests for risk of prostate cancer are not clinically useful in England. … READ MORE …

Consensus statement on pathologic factors and active surveillance

As previously mentioned earlier this week, a long statement that deals with the role of the pathologist in determining the suitability of patients for enrollment into active surveillance management protocols has been issued and endorsed by a number of organizations. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,254 other followers